Drug delivery strategy plays a major role within the future potential success of your product. Whether nurturing a new compound or developing a line of generic products, choosing the most effective delivery strategy can open the door to both opportunities, and hurdles. According to Markets and Markets, the drug delivery technologies market will eclipse $224 billion by 2017.
With an increasing diversity of compounds addressing more drug targets, the available range and sophistication of delivery technologies has expanded with the goal of increasing the successful rate of new chemical entities. Peptides, proteins, and nucleic acids also face similar delivery challenges.
August’s unique 2nd Drug Delivery Strategy: Advanced Mechanisms & Product Design event will showcase innovative delivery strategy examples from the industry’s leading delivery experts and manufacturers. With formulation playing a major role in the successes of a product, the right delivery platform, partnership sourcing and management of collaborations will be explored through a combination of novel case examples, keynote sessions and networking activities. Additionally, hear future regulatory and delivery technology updates, which will keep you ahead of the curve with your products. Topics include:
- Localized & targeted delivery
- Pediatric dosage forms & delivery
- QBD Strategy
- Novel alliance management strategies
- Enhancing patient adherence for drug delivery
- Evaluating innovations in oral drug formulation and delivery technologies
- Implementing innovative strategies around drug / device combinations
- Advances in ocular delivery
- Parenteral routes of administration
- Topical and Transdermal Delivery
- Modified release technologies for product lifecycle extensions
This must-attend event is co-located with Curtis & Coulter’s 3rd Annual Controlled & Modified Drug Release Event. Attendees have access to both events in the same location.
Benefits of Attending
Niya Bowers, PhD.
Deputy Director, Chemistry, Manufacturing and Controls, Bill and Melinda Gates Foundation
Esmaiel Jabbri, PhD.
Professor of Chemical Engineering, University of South Carolina
Marian Gindy, PhD.
Director, Parenteral Products Development, Merck & Co.
Who Should Attend
Pharmaceutical, biotech and academic professionals specializing in:
- Drug Delivery
- Formulation / Pre-Formulation
- Medicinal / Analytical / Solid state Chemistry
- Preclinical / Analytical Development
- Product Enhancement / Development
- Regulatory Affairs
- Drug Discovery
- Life-Cycle / Portfolio Management
- Partnering, Licensing & Alliance Management
- Intellectual Property
- Process R&D
2016’s Participating Companies Include
- Agios Pharmaceuticals
- Bill & Mellinda Gates Foundation
- BioPharma Services
- Boehringer Ingelheim
- Bristol Myers Squibb
- Cleave Biosciences
- Dalton Pharma Services
- Enteris Biopharma
- Forsee Pharma
- Frontage Labs
- Gilead Sciences
- Johnson & Johnson
- KVK Tech
- Lauren Sciences LLC
- Merck & Co.
- Microchips Biotech
- NOF America
- Piramal Pharma
- Princeton University
- Purdue University
- R.W. Hartnett Company
- University of South Carolina
- University of The Sciences
- And many more…
Download Attendee List
Past Event Brochure
Questions / Comments? Contact Paul at
+1 (646) 604-2830